211 related articles for article (PubMed ID: 16187598)
21. Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study.
Soubrane G; Harding SP; Wolf S; Weichselberger A
Eye (Lond); 2009 Apr; 23(4):791-800. PubMed ID: 18583995
[TBL] [Abstract][Full Text] [Related]
22. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Japanese Age-Related Macular Degeneration Tial (JAT) Study Group
Am J Ophthalmol; 2003 Dec; 136(6):1049-61. PubMed ID: 14644215
[TBL] [Abstract][Full Text] [Related]
23. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.
Blumenkranz MS; Bressler NM; Bressler SB; Donati G; Fish GE; Haynes LA; Lewis H; Miller JW; Monés JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Schachat AP; Schmidt-Erfurth U; Sickenburg M; Singerman LJ; Slakter JS; Strong A; Vannier S;
Arch Ophthalmol; 2002 Oct; 120(10):1307-14. PubMed ID: 12365909
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration.
Karacorlu M; Karacorlu S; Ozdemir H
Jpn J Ophthalmol; 2003; 47(6):595-8. PubMed ID: 14636851
[TBL] [Abstract][Full Text] [Related]
26. Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report.
Fujii GY; de Juan E; Pieramici DJ; Humayun MS; Phillips S; Reynolds SM; Melia M; Schachat AP
Am J Ophthalmol; 2002 Jul; 134(1):69-74. PubMed ID: 12095810
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
[TBL] [Abstract][Full Text] [Related]
28. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
Blinder KJ; Bradley S; Bressler NM; Bressler SB; Donati G; Hao Y; Ma C; Menchini U; Miller J; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Strong HA; Stur M; Su XY; Virgili G; ;
Am J Ophthalmol; 2003 Sep; 136(3):407-18. PubMed ID: 12967792
[TBL] [Abstract][Full Text] [Related]
29. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
Pieramici DJ; Bressler SB; Koester JM; Bressler NM
Arch Ophthalmol; 2006 May; 124(5):660-4. PubMed ID: 16682587
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
[TBL] [Abstract][Full Text] [Related]
31. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration.
Pawlak D; Glacet-Bernard A; Papp M; Roquet W; Coscas G; Soubrane G
Am J Ophthalmol; 2004 May; 137(5):880-7. PubMed ID: 15126153
[TBL] [Abstract][Full Text] [Related]
32. Spotlight on verteporfin in subfoveal choroidal neovascularisation.
Keam SJ; Scott LJ; Curran MP
Drugs Aging; 2004; 21(3):203-9. PubMed ID: 14979737
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
34. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.
Verteporfin Roundtable Participants
Retina; 2005; 25(2):119-34. PubMed ID: 15689800
[TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Sharma S; Brown GC; Brown MM; Hollands H; Shah GK
Ophthalmology; 2001 Nov; 108(11):2051-9. PubMed ID: 11713079
[TBL] [Abstract][Full Text] [Related]
36. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.
Kaiser PK;
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1132-42. PubMed ID: 16538452
[TBL] [Abstract][Full Text] [Related]
37. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
Retina; 2006; 26(9):988-93. PubMed ID: 17151484
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration: results of an effectiveness study.
Sharma S; Bakal J; Oliver-Fernandez A; Blair J
Arch Ophthalmol; 2004 Jun; 122(6):853-6. PubMed ID: 15197060
[TBL] [Abstract][Full Text] [Related]
39. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan WM; Lai TY; Wong AL; Tong JP; Liu DT; Lam DS
Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
